In NSCLC cell lines A549 and H460, miR-129-5p reduces CSC markers’ expression, self-renewal ability, and chemoresistance through inhibition of delta-like 1 homolog (DLK1). The gene discussed is DLK1; the disease is non-small cell lung carcinoma.